HEAP will provide a research resource for the integrated and efficient analysis of the human exposome. One primary outcome of the project is the complete process for obtaining actionable knowledge from the following sustainable co...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PTQ2021-012144
ChemDISGENET: Combining genetics and chemical exposure to su...
116K€
Cerrado
MTM2015-68140-R
METODOS ESTADISTICOS, ALGORITMOS EFICIENTES Y HERRAMIENTAS B...
Cerrado
BiomeDxRx
Microbiome-based diagnostics and therapeutics
150K€
Cerrado
EMIF
European Medical Information Framework
56M€
Cerrado
EpiGen Ethiopia
BUILDING SCALABLE PATHOGEN GENOMIC EPIDEMIOLOGY FOR ETHIOPIA
5M€
Cerrado
PID2021-122855OB-I00
RADIOGENOMICA PARA LA MEDICINA PERSONALIZADA EN LA ENFERMEDA...
157K€
Cerrado
Información proyecto HEAP
Duración del proyecto: 60 meses
Fecha Inicio: 2019-12-06
Fecha Fin: 2024-12-31
Líder del proyecto
KAROLINSKA INSTITUTET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
12M€
Descripción del proyecto
HEAP will provide a research resource for the integrated and efficient analysis of the human exposome. One primary outcome of the project is the complete process for obtaining actionable knowledge from the following sustainable cohorts: 1) a nation-wide Maternity Cohort where the impact of exposures on the health of women and children is supported by measures from wearable exposure sensors and metabolomics analysis, 2) a large cervical screening cohort enabling studies on women´s health supported with systematic epigenomics and metagenomics analyses, 3) and the systematic collection of consumer purchasing receipts linked to health outcomes will open new possibilities for assessing the impact of exposures on health in households. HEAP will launch a state-of-the-science informatics infrastructure (IaaS) composed of prime ICT resources from partner institutions in several EU countries, accessed through a software platform (PaaS) that includes the world’s fastest Hadoop platform to provide data warehousing and applied AI. The platform customised for exposome assessment will provide a decision support system for researchers, policymakers, and industry. All the data managed and processed by HEAP will be available for future research as well as the developed analyses. The platform can be enriched with new data and analysis pipelines and can be deployed in multiple instances to create a HEAP network towards producing shareable and reusable knowledge to promote health in society. HEAP will be under the umbrella of the European Human Exposome Network and will actively commit to collaboration and sharing of results and outcomes as well as contribute to i) a common ethical and regulatory framework, ii) common standardization and FAIRness of exposome data and iii) common dissemination strategies and efforts.